Logos Global Management LP - TALARIS THERAPEUTICS INC ownership

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 52 filers reported holding TALARIS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Logos Global Management LP ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$521,000
-57.4%
197,913
-27.0%
0.06%
-71.4%
Q2 2022$1,222,000
-59.4%
270,987
-11.5%
0.22%
-42.7%
Q1 2022$3,013,000
-40.1%
306,236
-6.9%
0.39%
-24.7%
Q4 2021$5,031,000
-26.9%
329,013
-35.2%
0.52%
+4.4%
Q3 2021$6,887,000
-7.7%
507,9230.0%0.50%
-20.7%
Q2 2021$7,461,000507,9230.63%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$5,513,2996.67%
BML Capital Management, LLC 1,929,484$3,627,4303.14%
Western Standard LLC 586,481$1,102,5841.12%
Cormorant Asset Management, LP 900,649$1,6930.11%
Artal Group S.A. 914,262$1,7190.10%
Values First Advisors, Inc. 52,896$99,4450.06%
Blackstone Inc. 8,089,315$15,207,9120.06%
Eventide Asset Management 1,561,092$2,934,8530.05%
Marquette Asset Management, LLC 101,375$190,5850.05%
VIKING GLOBAL INVESTORS LP 3,289,617$6,184,4800.03%
View complete list of TALARIS THERAPEUTICS INC shareholders